azelaic acid has been researched along with Inflammation in 13 studies
nonanedioic acid : An alpha,omega-dicarboxylic acid that is heptane substituted at positions 1 and 7 by carboxy groups.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "0001) number of patients demonstrated improvement over their previous acne treatment regimens after both 4 and 8 weeks of NicAzel (nicotinamide, azelaic acid, zinc, pyridoxine, copper, folic acid; Elorac Inc, Vernon Hills, IL) use." | 5.16 | Inflammatory acne management with a novel prescription dietary supplement. ( Akhavan, A; Day, D; Falcon, R; Iannotta, P; Janiga, A; Kallal, JE; Olansky, A; Shalita, AR; Singri, P, 2012) |
| "This study evaluated the efficacy and tolerability of treating mild-to-moderate facial acne using a new, hand-held, light-emitting diode blue light device in conjunction with a foam cleanser containing 5% glycolic acid and 2% salicylic acid plus a skin rebuilding serum containing 1." | 5.15 | Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system. ( Dhawan, S; Wheeland, RG, 2011) |
| "Recognition that acne is an inflammatory condition, not an infectious one, has led to a call for reduction in antibiotic use." | 2.61 | An Overview of Acne Therapy, Part 1: Topical therapy, Oral Antibiotics, Laser and Light Therapy, and Dietary Interventions. ( Baldwin, HE; Marson, JW, 2019) |
| " At present, subantimicrobial dosing of a tetracycline agent that also maintains anti-inflammatory activity has only been established with doxycycline." | 2.48 | Optimal management of papulopustular rosacea: rationale for combination therapy. ( Bhatia, ND; Del Rosso, JQ, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Marson, JW | 1 |
| Baldwin, HE | 1 |
| Del Rosso, JQ | 2 |
| Gallo, RL | 1 |
| Tanghetti, E | 1 |
| Webster, G | 1 |
| Thiboutot, D | 1 |
| Shokeen, D | 1 |
| Kircik, LH | 1 |
| Wheeland, RG | 1 |
| Dhawan, S | 1 |
| Bhatia, ND | 1 |
| Matsubara, T | 1 |
| Tanaka, N | 1 |
| Krausz, KW | 1 |
| Manna, SK | 1 |
| Kang, DW | 1 |
| Anderson, ER | 1 |
| Luecke, H | 1 |
| Patterson, AD | 1 |
| Shah, YM | 1 |
| Gonzalez, FJ | 1 |
| Shalita, AR | 1 |
| Falcon, R | 1 |
| Olansky, A | 1 |
| Iannotta, P | 1 |
| Akhavan, A | 1 |
| Day, D | 1 |
| Janiga, A | 1 |
| Singri, P | 1 |
| Kallal, JE | 1 |
| Lindow, KB | 1 |
| Cayce, KA | 1 |
| McMichael, AJ | 1 |
| Feldman, SR | 1 |
| Draelos, ZD | 1 |
| Green, BA | 1 |
| Edison, BL | 1 |
| Akamatsu, H | 1 |
| Komura, J | 1 |
| Asada, Y | 1 |
| Miyachi, Y | 1 |
| Niwa, Y | 1 |
6 reviews available for azelaic acid and Inflammation
| Article | Year |
|---|---|
An Overview of Acne Therapy, Part 1: Topical therapy, Oral Antibiotics, Laser and Light Therapy, and Dietary Interventions.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Combined Moda | 2019 |
An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea.
Topics: Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Humans; Immunity, Innate; Inflammation; Low-Le | 2013 |
Postinflammatory hyperpigmentation in patients with skin of color.
Topics: Chemexfoliation; Dermatitis; Dermatologic Agents; Dicarboxylic Acids; Drug Combinations; Ethanol; Gl | 2016 |
Optimal management of papulopustular rosacea: rationale for combination therapy.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Inflammatory Agents; Dermatologic Agents; Dica | 2012 |
Rosacea. An overview of diagnosis and management.
Topics: Anti-Infective Agents; Body Image; Dermatologic Agents; Diagnosis, Differential; Dicarboxylic Acids; | 2004 |
Hyperpigmentation: an overview of the common afflictions.
Topics: Chemexfoliation; Cryotherapy; Dermatologic Agents; Dicarboxylic Acids; Humans; Hydroquinones; Hyperp | 2004 |
4 trials available for azelaic acid and Inflammation
| Article | Year |
|---|---|
Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study.
Topics: Acne Vulgaris; Administration, Cutaneous; Black People; Dermatologic Agents; Dicarboxylic Acids; Fem | 2011 |
Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system.
Topics: Acne Vulgaris; Adult; Combined Modality Therapy; Dermatologic Agents; Dicarboxylic Acids; Drug Combi | 2011 |
Inflammatory acne management with a novel prescription dietary supplement.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Child; Copper; Dicarboxylic Acids; Dietary | 2012 |
An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients.
Topics: Dermatologic Agents; Dicarboxylic Acids; Erythema; Female; Gels; Humans; Inflammation; Rosacea; Sing | 2006 |
3 other studies available for azelaic acid and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Metabolomics identifies an inflammatory cascade involved in dioxin- and diet-induced steatohepatitis.
Topics: Animals; Carboxylic Ester Hydrolases; Cells, Cultured; Dicarboxylic Acids; Diet; Fatty Liver; Hepato | 2012 |
Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases.
Topics: Chemotaxis; Dermatologic Agents; Dicarboxylic Acids; Humans; Hydroxides; Inflammation; Neutrophils; | 1991 |